← Back to headlines
TD Cowen Raises Abbott Labs Price Target on Cancer Diagnostics Growth
TD Cowen has increased its stock price target for Abbott Laboratories, citing strong growth in the company's cancer diagnostics segment as the primary driver for the upgrade.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Trump Administration Announces Major Oil Deal to Replenish U.S. Strategic Reserve
28m ago
NATO Warns of Escalating Russian Gray Zone Attacks Across Europe
50m ago
Investors Eye Jobs Data and Major Earnings Reports for Market Direction
1h ago
North Korea Replaces Defense Minister in Military Shake-Up
2h ago